130 related articles for article (PubMed ID: 26925649)
1. New Prognostic Scoring System for Incurable Stage IV Colorectal Cancer.
Kishiki T; Masaki T; Mastuoka H; Abe N; Mori T; Sugiyama M
Asian Pac J Cancer Prev; 2016; 17(2):597-601. PubMed ID: 26925649
[TBL] [Abstract][Full Text] [Related]
2. Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection.
Tokunaga R; Sakamoto Y; Nakagawa S; Izumi D; Kosumi K; Taki K; Higashi T; Miyata T; Miyamoto Y; Yoshida N; Baba H
Int J Clin Oncol; 2017 Aug; 22(4):740-748. PubMed ID: 28213742
[TBL] [Abstract][Full Text] [Related]
3. Glasgow prognostic score is a useful predictive factor of outcome after palliative gastrectomy for stage IV gastric cancer.
Mimatsu K; Oida T; Fukino N; Kano H; Kawasaki A; Kida K; Kuboi Y; Amano S
Anticancer Res; 2014 Jun; 34(6):3131-6. PubMed ID: 24922683
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Lower Body Mass Index Correlates with Poorer Prognosis in Patients Undergoing Curative Laparoscopic Surgery for Colorectal Cancer.
Uratani R; Toiyama Y; Shimura T; Mori K; Fujikawa H; Hiro J; Ohi M; Inoue Y; Tanaka K; Araki T; Mohri Y; Kusunoki M
Anticancer Res; 2015 Oct; 35(10):5639-48. PubMed ID: 26408737
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy.
Li QQ; Lu ZH; Yang L; Lu M; Zhang XT; Li J; Zhou J; Wang XC; Gong JF; Gao J; Li J; Li Y; Shen L
Asian Pac J Cancer Prev; 2014; 15(2):945-50. PubMed ID: 24568523
[TBL] [Abstract][Full Text] [Related]
6. Hematologic Markers of Lung Metastasis in Stage IV Colorectal Cancer.
Abu-Shawer M; Abu-Shawer O; Souleiman M; Akkawi M; Alshakhatreh O; Altamimi T; Al-Omari A; Al-Hussaini M
J Gastrointest Cancer; 2019 Sep; 50(3):428-433. PubMed ID: 29589285
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer.
Wang F; He W; Jiang C; Guo G; Ke B; Dai Q; Long J; Xia L
BMC Cancer; 2018 Nov; 18(1):1102. PubMed ID: 30419863
[TBL] [Abstract][Full Text] [Related]
8. Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer.
Takamizawa Y; Shida D; Boku N; Nakamura Y; Ahiko Y; Yoshida T; Tanabe T; Takashima A; Kanemitsu Y
BMC Cancer; 2020 Nov; 20(1):1092. PubMed ID: 33176752
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer.
Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores.
Dolan RD; McSorley ST; Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
Br J Cancer; 2018 Jul; 119(1):40-51. PubMed ID: 29789606
[TBL] [Abstract][Full Text] [Related]
11. Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases.
Neal CP; Cairns V; Jones MJ; Masood MM; Nana GR; Mann CD; Garcea G; Dennison AR
Med Oncol; 2015 May; 32(5):144. PubMed ID: 25807934
[TBL] [Abstract][Full Text] [Related]
12. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
13. Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host.
Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
Ann Surg; 2016 Feb; 263(2):326-36. PubMed ID: 25575264
[TBL] [Abstract][Full Text] [Related]
14. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
15. The modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases.
Nakagawa K; Tanaka K; Nojiri K; Kumamoto T; Takeda K; Ueda M; Endo I
Ann Surg Oncol; 2014 May; 21(5):1711-8. PubMed ID: 24452408
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of the high-sensitivity modified Glasgow prognostic score in patients with resectable non-small cell lung cancer.
Osugi J; Muto S; Matsumura Y; Higuchi M; Suzuki H; Gotoh M
J Cancer Res Ther; 2016; 12(2):945-51. PubMed ID: 27461679
[TBL] [Abstract][Full Text] [Related]
17. Utility of Inflammatory Marker- and Nutritional Status-based Prognostic Factors for Predicting the Prognosis of Stage IV Gastric Cancer Patients Undergoing Non-curative Surgery.
Mimatsu K; Fukino N; Ogasawara Y; Saino Y; Oida T
Anticancer Res; 2017 Aug; 37(8):4215-4222. PubMed ID: 28739709
[TBL] [Abstract][Full Text] [Related]
18. Preoperative platelet-lymphocyte ratio is an independent prognostic marker and superior to carcinoembryonic antigen in colorectal peritoneal carcinomatosis patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Bong TSH; Tan GHC; Chia C; Soo KC; Teo MCC
Int J Clin Oncol; 2017 Jun; 22(3):511-518. PubMed ID: 28138878
[TBL] [Abstract][Full Text] [Related]
19. Inflammation-based prognostic scores as indicators to select candidates for primary site resection followed by multimodal therapy among colorectal cancer patients with multiple metastases.
Shimura T; Toiyama Y; Saigusa S; Imaoka H; Okigami M; Fujikawa H; Hiro J; Kobayashi M; Ohi M; Araki T; Inoue Y; Uchida K; Mohri Y; Kusunoki M
Int J Clin Oncol; 2017 Aug; 22(4):758-766. PubMed ID: 28299463
[TBL] [Abstract][Full Text] [Related]
20. Prognostic scoring system for stage IV colorectal cancer: is the AJCC sub-classification of stage IV colorectal cancer appropriate?
Kobayashi H; Kotake K; Sugihara K
Int J Clin Oncol; 2013 Aug; 18(4):696-703. PubMed ID: 22692571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
